Christopher Ambrose

All papers authored by Christopher Ambrose

This paper is made freely available by the publisher.

2019 Heather L. Gelhorn, Zaneta Balantac

, Christopher S. Ambrose

, Yen N. Chung

, Brian Stone

Patient and physician preferences for attributes of biologic medications for severe asthma

Download from doi.org

2018 Mihoko V. Bennett, Kimmie McLaurin, Christopher Ambrose

, Henry C. Lee

Population-based trends and underlying risk factors for infant respiratory syncytial virus and bronchiolitis hospitalizations

Download from doi.org

Christopher S. Ambrose

Is It RSV?

Download from doi.org

2017 Katherine A. Poehling, Herve Caspard, Timothy R. Peters, Edward A. Belongia, Blaise Congeni, Manjusha Gaglani, Marie R. Griffin, Stephanie A. Irving, Poornima K. Kavathekar, Huong Q. McLean, Allison L. Naleway, Kathleen Ryan, H. Keipp Talbot, Christopher S. Ambrose

2015–2016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States

Download from academic.oup.com

Rohan C. Parikh, Kimmie K. McLaurin, Andrea V. Margulis, Josephine Mauskopf, Christopher S. Ambrose

, Melissa Pavilack, Sean D. Candrilli

Chronologic Age at Hospitalization for Respiratory Syncytial Virus Among Preterm and Term Infants in the United States

Download from doi.org

Huong Q. McLean, Herve Caspard, Marie R. Griffin, Katherine A. Poehling, Manjusha Gaglani, Edward A. Belongia, H. Keipp Talbot, Timothy R. Peters, Kempapura Murthy, Christopher S. Ambrose

Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014–2015 season

Download from doi.org

Roger Baxter, Abigail Eaton, John Hansen, Laurie Aukes, Herve Caspard, Christopher S. Ambrose

Corrigendum to “Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2–49 years” [Vaccine 35 (2017) 1254–1258]

Download from doi.org

Deborah Friedman, Jon Fryzek, Xiaohui Jiang, Adam Bloomfield, Christopher S. Ambrose

, Pierre C. Wong

Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses

Download from doi.org

This paper is available in a repository.

Christopher S. Ambrose

Statistical Power to Detect an Association Between Guideline-based Palivizumab Administration and Hospitalizations for Respiratory Syncytial Virus Infections

Download from www.ncbi.nlm.nih.gov

Roger Baxter, Abigail Eaton, John Hansen, Laurie Aukes, Herve Caspard, Christopher S. Ambrose

Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2–49years

Download from doi.org

Susan T. Pastula, Judith Hackett, Jenna Coalson, Xiaohui Jiang, Tonya Villafana, Christopher Ambrose

, Jon Fryzek

Hospitalizations for respiratory syncytial virus among adults in the United States, 1997-2012

Download from doi.org

2016 Eric A. F. Simões, Evan J. Anderson, Xionghua Wu, Christopher S. Ambrose

Effects of Chronologic Age and Young Child Exposure on Respiratory Syncytial Virus Disease among US Preterm Infants Born at 32 to 35 Weeks Gestation

Download from doi.org

Christopher S. Ambrose

, Helen Bright, Raburn Mallory

Letter to the editor: Potential causes of the decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated influenza vaccines

Download from doi.org

Herve Caspard, Kathleen L. Coelingh, Raburn M. Mallory, Christopher S. Ambrose

Association of vaccine handling conditions with effectiveness of live attenuated influenza vaccine against H1N1pdm09 viruses in the United States

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Evan Anderson, Leonard Krilov, John DeVincenzo, Paul Checchia, Natasha Halasa, Eric Simões, Joseph Domachowske, Michael Forbes, Pia Pannaraj, Scott McBride, Kimmie McLaurin, Christopher Ambrose

, Veena Kumar

SENTINEL1: An Observational Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis

Upload

Abigail Doucette, Xiaohui Jiang, Jon Fryzek, Jenna Coalson, Kimmie McLaurin, Christopher S. Ambrose

Trends in Respiratory Syncytial Virus and Bronchiolitis Hospitalization Rates in High-Risk Infants in a United States Nationally Representative Database, 1997-2012

Download from doi.org

John P. DeVincenzo, Christopher S. Ambrose

, Doris Makari, Leonard B. Weiner

Evaluation of Recent New Vaccine Surveillance Network Data Regarding Respiratory Syncytial Virus Hospitalization Rates in US Preterm Infants

Download from www.tandfonline.com

Herve Caspard, Terho Heikkinen, Robert B. Belshe, Christopher S. Ambrose

A Systematic Review of the Efficacy of Live Attenuated Influenza Vaccine Upon Revaccination of Children

Download from www.tandfonline.com

Herve Caspard, Manjusha Gaglani, Lydia Clipper, Edward A. Belongia, Huong Q. McLean, Marie R. Griffin, H. Keipp Talbot, Katherine A. Poehling, Timothy R. Peters, Naomi Veney, Christopher S. Ambrose

Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2–17 years of age in 2013–2014 in the United States

Upload

Jeremy A. Franklin, Evan J. Anderson, Xionghua Wu, Christopher S. Ambrose

, Eric A. F. Simões

Insurance Status and the Risk of Severe Respiratory Syncytial Virus Disease in United States Preterm Infants Born at 32–35 Weeks Gestational Age

Download from doi.org

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Christopher Ambrose